International Guillain-Barré Syndrome Outcome Study

Completed

Conditions studied: Guillain-Barré Syndrome, Miller Fisher Syndrome

In brief

International GBS Outcome Study (IGOS) is a study conducted by the members of the Inflammatory Neuropathy Consortium (INC) and Peripheral Nerve Society (PNS) on disease course and outcome in Guillain-Barré syndrome (GBS). The IGOS aims to identify clinical and biological determinants and predictors of disease course and outcome in individual patients with Guillain-Barré syndrome, as early as possible after onset of disease.

Key facts

Study ID

NCT01582763

Run by

Erasmus Medical Center

People needed

2000

Starts

2012-05-01

Expected to finish

2024-12-02

Last updated by the study team

2024-12-12

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Fulfil diagnostic criteria for GBS of National Institute of Neurological Disorders and Stroke (NINDS). Patients with Miller Fisher syndrome and all other variants of GBS, including overlap syndromes, can be included.
• Inclusion of all males and females of all ages, independent of disease severity and treatment
• Inclusion within two weeks of onset of weakness
• Inclusion of patients transferred from another hospital if the stay in the first hospital was less than one week
• Opportunity to conduct a follow-up of at least one year
• Informed consent of patient or, in case of children, of parents or legal guardians

You may not qualify if…

• There are no exclusion criteria

Where it is running

• UC Irvine Health — Orange, California, United States
• Yale University School of medicine — New Haven, Connecticut, United States
• University of Florida — Jacksonville, Florida, United States
• Northwestern University — Chicago, Illinois, United States
• Southern Illinois University School of Medicine — Springfield, Illinois, United States
• University of Iowa — Iowa City, Iowa, United States
• University of Kansas Medical Center — Kansas City, Kansas, United States
• University of Maryland School of Medicine — Baltimore, Maryland, United States
• Johns Hopkins — Baltimore, Maryland, United States
• Lahey clinic Boston — Boston, Massachusetts, United States
• Tufts University School of Medicine — Boston, Massachusetts, United States
• Spectrum Health System — Grand Rapids, Michigan, United States
• University of Minnesota — Minneapolis, Minnesota, United States
• Robert Wood Johnson Medical School — New Brunswick, New Jersey, United States
• University of New Mexico — Albuquerque, New Mexico, United States
• University at Buffalo — Buffalo, New York, United States
• Mt. Sinai School of Med — New York, New York, United States
• Columbia University — New York, New York, United States
• Montefiore MC — New York, New York, United States
• Wexner Medical Center at The Ohio State University — Columbus, Ohio, United States
• University of Tennessee — Memphis, Tennessee, United States
• UT Southwestern — Dallas, Texas, United States
• The university of Texas Health Science Center — Houston, Texas, United States
• University of Utah School of Medicine — Salt Lake City, Utah, United States
• Barrows Neurological Institute — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.